Published in Am J Physiol Heart Circ Physiol on May 02, 2008
Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling. Respir Res (2011) 1.03
Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats. Am J Physiol Lung Cell Mol Physiol (2013) 1.01
HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. Cardiovasc Res (2010) 0.98
PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling. FASEB J (2011) 0.94
Skeletal and cardiac myopathy in HIV-1 transgenic rats. Am J Physiol Endocrinol Metab (2008) 0.92
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction. PLoS One (2014) 0.85
Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children. Future Virol (2011) 0.85
HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med (2012) 0.83
Effect of medial calcification on vascular function in uremia. Am J Physiol Renal Physiol (2011) 0.82
Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients. PLoS One (2012) 0.81
Oxidative Stress during HIV Infection: Mechanisms and Consequences. Oxid Med Cell Longev (2016) 0.81
AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats. Br J Pharmacol (2011) 0.80
Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development. Pulm Circ (2013) 0.79
Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets. Viruses (2014) 0.79
Focus on the lung. Alcohol Res Health (2010) 0.76
Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats. PLoS One (2017) 0.75
HIV-1 decreases Nrf2/ARE activity and phagocytic function in alveolar macrophages. J Leukoc Biol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol (1996) 13.14
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res (2000) 10.95
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation (2006) 5.91
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1992) 4.25
Endothelial function in HIV-infected persons. Clin Infect Dis (2006) 3.80
Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med (1998) 3.51
Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol (2006) 3.48
Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol (2002) 3.39
Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res (1998) 3.30
Measurement of reactive oxygen species in cardiovascular studies. Hypertension (2007) 3.17
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation (2005) 3.12
Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet (1989) 3.01
Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A (2001) 2.96
Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol (2006) 2.94
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med (2003) 2.83
Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension (1998) 2.70
Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol (2004) 2.66
Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol (2004) 2.61
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A (1992) 2.48
Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med (1998) 2.44
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) (2006) 2.24
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem (1994) 2.20
Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A (1997) 2.20
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis (2002) 2.19
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology (1991) 2.16
Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem (1994) 2.04
Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1992) 1.95
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. AIDS (2001) 1.81
Cardiovascular disease in HIV infection. Am Heart J (2006) 1.78
A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen. J Acquir Immune Defic Syndr (2006) 1.76
Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res (2002) 1.64
Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation (2006) 1.50
Glutathione availability modulates alveolar macrophage function in the chronic ethanol-fed rat. Am J Physiol Lung Cell Mol Physiol (2006) 1.47
Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res (2002) 1.42
Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol (2005) 1.42
Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci U S A (1993) 1.39
Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension (2000) 1.36
Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis (1991) 1.35
The role of oxidative stress in HIV disease. Free Radic Biol Med (1995) 1.34
Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J Biol Chem (2000) 1.32
ESR techniques for the detection of nitric oxide in vivo and in tissues. Methods Enzymol (2005) 1.32
Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors. Lab Invest (2001) 1.28
Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol (1987) 1.28
Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS (2004) 1.23
Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS (1998) 1.23
Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice. Cardiovasc Res (2003) 1.20
Reactive oxygen species and nitric oxide in viral diseases. Biol Trace Elem Res (1997) 1.13
Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) (2004) 1.11
Infections and systemic vasculitis. Curr Opin Rheumatol (1998) 1.07
Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol (2002) 1.07
Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact (1994) 1.06
Atherosclerosis: risk factors and the vascular endothelium. Am Heart J (1996) 1.04
Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity. Methods Mol Med (2007) 1.03
Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg (2003) 1.03
The endothelium in health and disease--a target for therapeutic intervention. J Smooth Muscle Res (2003) 1.03
The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukoc Biol (1992) 1.03
The HIV-1 Nef protein and phagocyte NADPH oxidase activation. J Biol Chem (2002) 1.02
HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest (2002) 1.01
Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol (2005) 1.01
Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents. Cardiovasc Toxicol (2004) 1.01
Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr (1992) 1.00
Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo. Am J Physiol Regul Integr Comp Physiol (2005) 1.00
Tumor necrosis factor-alpha down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radic Biol Med (2006) 1.00
HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS (1998) 1.00
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension. J Nutr (2005) 0.98
Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost (1997) 0.97
AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS. Am J Physiol Heart Circ Physiol (2005) 0.96
Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. J Clin Microbiol (1991) 0.95
Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology (2002) 0.95
Endothelial dysfunction: clinical strategies for treating oxidant stress. Am Heart J (2003) 0.94
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. J Virol (2004) 0.94
HIV-1 Nef regulates the release of superoxide anions from human macrophages. Biochem J (2005) 0.92
HIV-1-induced pulmonary oxidative and nitrosative stress: exacerbated response to endotoxin administration in HIV-1 transgenic mouse model. Am J Physiol Lung Cell Mol Physiol (2006) 0.89
Cardiovascular risk factors in HIV-infected patients. J Acquir Immune Defic Syndr (2003) 0.87
Endothelium-dependent vasorelaxation in inhibited by in vivo depletion of vascular thiol levels: role of endothelial nitric oxide synthase. Free Radic Res (2001) 0.84
Cerebral aneurysm in the HIV patient: a report of six cases. Surg Neurol (1996) 0.83
Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother (2004) 0.82
Modulation of lymphocyte interaction with endothelium and homing by HIV-1 gp120. J Immunol (1997) 0.81
Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteins. J Virol (1999) 0.81
Soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in patients with HIV/AIDS does not appear to correlate with cytomegalovirus retinitis. Int J STD AIDS (1998) 0.81
Effects of HIV co-infection and chemotherapy on the urinary levels of nitric oxide metabolites in patients with pulmonary tuberculosis. Scand J Infect Dis (1999) 0.81
Decreased exhaled nitric oxide in subjects with HIV infection. Thorax (1997) 0.79
A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production. J Leukoc Biol (2001) 0.79
HIV-related vasculitis. AIDS Patient Care STDS (1997) 0.77
Levels of nitric oxide, gamma interferon and interleukin-12 in AIDS patients with toxoplasmic encephalitis. Infection (1999) 0.77
Nasal nitric oxide is reduced in patients with HIV. Acta Otolaryngol (2000) 0.76
Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction. Thromb Haemost (1998) 0.76
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature (2004) 5.85
NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res (2005) 4.66
Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem (2003) 3.23
Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension (2002) 3.23
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation (2005) 3.12
Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation (2010) 2.95
Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol (2004) 2.94
Role of extracellular superoxide dismutase in hypertension. Hypertension (2006) 2.74
Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol (2006) 2.48
Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radic Biol Med (2007) 2.47
Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol (2008) 2.44
Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr (2004) 2.41
Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta (2008) 2.35
Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med (2003) 2.27
Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring) (2008) 2.23
Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem (2003) 2.14
Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci (2004) 2.12
Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol (2003) 2.09
Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater (2008) 2.05
Cytokines and alcohol. Alcohol Clin Exp Res (2006) 2.04
Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis (2005) 2.02
Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res (2007) 2.01
apLCMS--adaptive processing of high-resolution LC/MS data. Bioinformatics (2009) 1.98
Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr (2003) 1.93
Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem (2004) 1.90
Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation (2005) 1.90
Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol (2009) 1.88
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation (2002) 1.87
Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J (2007) 1.86
Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med (2003) 1.82
Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol (2002) 1.81
Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. Am J Physiol Heart Circ Physiol (2007) 1.81
Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem J (2005) 1.78
Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem (2007) 1.72
Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nutr (2007) 1.66
Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol (2005) 1.66
Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem (2005) 1.65
The role of plasma aminothiols in the prediction of coronary microvascular dysfunction and plaque vulnerability. Atherosclerosis (2011) 1.62
xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics (2013) 1.61
PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. Am J Physiol Lung Cell Mol Physiol (2010) 1.60
DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest (2014) 1.59
Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage. J Immunol (2005) 1.59
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol (2006) 1.59
The alcoholic lung: epidemiology, pathophysiology, and potential therapies. Am J Physiol Lung Cell Mol Physiol (2007) 1.58
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial). J Cardiovasc Electrophysiol (2010) 1.57
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol (2004) 1.57
Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome? JPEN J Parenter Enteral Nutr (2007) 1.55
NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem (2002) 1.53
Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2005) 1.52
Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic Biol Med (2002) 1.51
Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation (2006) 1.50
The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am J Respir Cell Mol Biol (2008) 1.49
Chronic alcohol ingestion primes the lung for bleomycin-induced fibrosis in mice. Alcohol Clin Exp Res (2013) 1.49
Thioredoxin and its role in toxicology. Toxicol Sci (2003) 1.48
The redox proteome. J Biol Chem (2013) 1.48
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs (2005) 1.48
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol (2007) 1.47
Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state. Invest Ophthalmol Vis Sci (2005) 1.47
Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem (2002) 1.46
The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res (2005) 1.46
Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation (2003) 1.45
Reduced ENaC protein abundance contributes to the lower blood pressure observed in pendrin-null mice. Am J Physiol Renal Physiol (2007) 1.45
Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic Biol Med (2005) 1.44
Predicting network activity from high throughput metabolomics. PLoS Comput Biol (2013) 1.44
Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci (2006) 1.43
Dietary supplementation with orotate and uracil increases adaptive growth of jejunal mucosa after massive small bowel resection in rats. JPEN J Parenter Enteral Nutr (2005) 1.43
Metabolic effects of albumin therapy in acute lung injury measured by proton nuclear magnetic resonance spectroscopy of plasma: a pilot study. Crit Care Med (2011) 1.42
Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med (2010) 1.42
Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 1.41
A practical approach to detect unique metabolic patterns for personalized medicine. Analyst (2010) 1.41
Glutathione replacement preserves the functional surfactant phospholipid pool size and decreases sepsis-mediated lung dysfunction in ethanol-fed rats. Alcohol Clin Exp Res (2002) 1.40
Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gastrointest Liver Physiol (2002) 1.40
Transforming growth factor beta1 expression and activation is increased in the alcoholic rat lung. Am J Respir Crit Care Med (2004) 1.39
Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J (2006) 1.39
A model of redox kinetics implicates the thiol proteome in cellular hydrogen peroxide responses. Antioxid Redox Signal (2010) 1.38
Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A (2010) 1.38
Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol (2007) 1.34
Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med (2004) 1.34
The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol (2012) 1.34
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.33
Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys (2007) 1.33
Association between adherence to the Mediterranean diet and oxidative stress. Am J Clin Nutr (2008) 1.32
Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na(+)-K(+)-2Cl(-) cotransporter. Am J Physiol Heart Circ Physiol (2002) 1.32
Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A (2007) 1.31
A key role for mitochondria in endothelial signaling by plasma cysteine/cystine redox potential. Free Radic Biol Med (2009) 1.31
Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol (2010) 1.31
Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS One (2009) 1.30
Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2. J Allergy Clin Immunol (2011) 1.30
Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J (2002) 1.30
Pendrin modulates ENaC function by changing luminal HCO3-. J Am Soc Nephrol (2010) 1.29